Full text
1/2026
vol. 77
Original paper
Single-step next-generation sequencing of immunoglobulin heavy chain genes to detect clonality in classical Hodgkin lymphoma
Department of Medical Biotechnology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Biobank of Research, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Department of Medical and Surgical Sciences, Bologna University School of Medicine, Bologna, Italy
Pol J Pathol 2026; 77 (1): 39-43
Data publikacji online: 2026/06/09
Article file
- Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB de O, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 2022; 36: 1720-1748.
- Ansell SM. Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol 2022; 97: 1478-1488.
- Van Dongen JJM, Langerak AW, Brüggemann M, Evans PAS, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257-2317.
- Han S, Masaki A, Sakamoto Y, Takino H, Murase T, Iida S, et al. Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: a paraffin-embedded tissue study. Pathol Int 2018; 68: 287-293.
- Gazzola A, Mannu C, Rossi M, Laginestra MA, Sapienza MR, Fuligni F, et al. The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies. Ther Adv Hematol 2014; 5: 35-47.
- Gazzola A, Navari M, Mannu C, Donelli R, Etebari M, Piccaluga PP. Single-step IGHV next-generation sequencing detects clonality and somatic hypermutation in lymphoid malignancies: a phase III diagnostic accuracy study. Cancers (Basel) 2023; 15: 4624.
- Oki Y, Neelapu SS, Fanale M, Kwak LW, Fayad L, Rodri- guez MA, et al. Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach. Br J Haematol 2015; 169: 689-693.
- Santisteban-Espejo A, Bernal-Florindo I, Perez-Requena J, Atienza-Cuevas L, Moran-Sanchez J, Fernandez-Valle M del C, et al. The need for standardization in next-generation sequencing studies for classic Hodgkin lymphoma: a systematic review. Diagnostics 2022; 12: 963.
- Gazzola A, Sabattini E, Mannu C, Bacci F, Sagramoso Sacchetti CA, Artioli P, et al. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up. Pathologica 2011; 103: 14-18.
- Langerak AW, Groenen PJTA, Brüggemann M, Beldjord K, Bellan C, Bonello L, et al. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia 2012; 26: 2159-2171.
- Arcila ME, Yu W, Syed M, Kim H, Maciag L, Yao J, et al. Establishment of immunoglobulin heavy (IGH) chain clonality testing by next-generation sequencing for routine characterization of B-cell and plasma cell neoplasms. J Mol Diagn 2019 M; 21: 330-342.
- Van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, et al. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol 2022; 35: 757-766.
- Ghorbian S, Jahanzad I, Javadi GR, Sakhinia E. Evaluation of IGK and IGL molecular gene rearrangements according to the BIOMED-2 protocols for clinical diagnosis of Hodgkin lymphoma. Hematology 2016; 21: 133-137.
- Zhang JJ, Xie YX, Luo LL, Yang XT, Wang YX, Cao Y, et al. A comparison of capillary electrophoresis and next-generation sequencing in the detection of immunoglobulin heavy chain H and light chain gene rearrangements in the diagnosis of classic hodgkin’s lymphoma. Bioengineered 2022; 13: 5868-5879.
- Van Bladel DAG, Stevens WBC, van den Brand M, Kroeze LI, Groenen PJTA, van Krieken JHJM, et al. Novel approaches in molecular characterization of classical Hodgkin lymphoma. Cancers (Basel) 2022; 14: 3222.
- Van Bladel DAG, van der Last-Kempkes JLM, Scheijen B, Groenen PJTA. EuroClonality Consortium. Next-generation sequencing-based clonality detection of immunoglobulin gene rearrangements in B-Cell lymphoma. Methods Mol Biol 2022; 2453: 7-42.
- Van Bladel DAG, van den Brand M, Rijntjes J, Pamidimarri Naga S, Haacke DLCM, Luijks JACW, et al. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Mod Pathol 2022; 35: 757-766.
- Van den Brand M, Rijntjes J, Möbs M, Steinhilber J, van der Klift MY, Heezen KC, et al. Next-generation sequencing-based clonality assessment of ig gene rearrangements: a multicenter validation study by EuroClonality-NGS. J Mol Diagn 2021; 23: 1105-1115.
- Deng X, Zhang M, Zhou J, Xiao M. Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside. Exp Hematol Oncol 2022; 11: 50.
- Brüggemann M, Kotrová M, Knecht H, Bartram J, Boud-jogrha M, Bystry V, et al. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study. Leukemia 2019; 33: 2241-2253.
- Heger JM, Mammadova L, Mattlener J, Sobesky S, Cirillo M, Altmüller J, et al. Circulating tumor DNA sequencing for biologic classification and individualized risk stratification in patients with Hodgkin lymphoma. J Clin Oncol 2024; 42: 4218-4230.
Copyright: © 2026 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
